Bulletin
Investor Alert

Prevail Therapeutics Inc.

NAS: PRVL

GO
/marketstate/country/us

After Hours

/zigman2/quotes/212754986/composite

$

11.00

Change

0.00 0.00%

Volume

Volume 54

Sep 23, 2020, 4:42 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/212754986/composite

Today's close

$ 11.31

$ 11.00

Change

-0.31 -2.74%

Day low

Day high

$10.96

$11.40

Open
Open: 11.36

52 week low

52 week high

$9.02

$19.96

Open

Market cap

$386.97M

Average volume

132,831

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-2.36

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/prvl

MarketWatch News on PRVL

  1. Prevail Therapeutics started at buy with $23 stock price target at Stifel Nicolaus

    8:25 a.m. July 16, 2020

    - Tomi Kilgore

  2. Our Roundtable Experts Pick 14 Biotech Stocks

    6:10 p.m. Oct. 2, 2019

    - Barron's Online

  3. Prevail Therapeutics started at outperform with $25 stock price target at Wedbush

    7:31 a.m. July 15, 2019

    - Tomi Kilgore

  4. Owens Corning Scrutinized

    9:30 p.m. July 5, 2019

    - Barron's Online

/news/nonmarketwatch/company/us/prvl

Other News on PRVL

  1. IPO Update: Inhibikase Therapeutics Proposes IPO Terms

    11:30 a.m. Sept. 17, 2020

    - Seeking Alpha

  2. 10-Q: PREVAIL THERAPEUTICS INC.

    7:11 a.m. Aug. 11, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  3. Stocks To Watch: Big Focus On Big Tech

    8:26 a.m. July 25, 2020

    - Seeking Alpha

  4. New Strong Buy Stocks for May 18th

    11:49 a.m. May 18, 2020

    - Zacks.com

  5. 10-Q: PREVAIL THERAPEUTICS INC.

    7:47 a.m. May 14, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  6. New Strong Buy Stocks for April 24th

    7:24 a.m. April 24, 2020

    - Zacks.com

  7. 10-K: PREVAIL THERAPEUTICS INC.

    8:12 a.m. March 26, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  8. Goldman likes GW Pharma in premarket analyst action

    8:22 a.m. March 6, 2020

    - Seeking Alpha

  9. Prevail Therapeutics (PRVL) Investor Presentation - Slideshow

    11:24 a.m. March 5, 2020

    - Seeking Alpha

  10. IPO Update: Passage Bio Finalizes $126 Million IPO Plan

    4:57 p.m. Feb. 18, 2020

    - Seeking Alpha

  11. Passage Bio Files Initial Plan For IPO

    1:10 p.m. Feb. 4, 2020

    - Seeking Alpha

  12. Loading more headlines...
/news/pressrelease/company/us/prvl

Press Releases on PRVL

  1. Loading more headlines...

Rates »

Link to MarketWatch's Slice.